The head of the U.S. Centers for Disease Control and Prevention (CDC) said Wednesday “now is not the time” to lift COVID-19 restrictions, one day after the governor of Texas announced the southern U.S. state was “100 percent open.”  At a virtual news briefing for the White House COVID-19 response, CDC Director Rochelle Walensky said the next month or two will be pivotal in deciding the trajectory of the pandemic.    FILE – In this image from video, CDC Director Dr. Rochelle Walensky speaks during a briefing on the Biden administration’s response to the COVID-19 pandemic, Jan. 27, 2021, in Washington. (White House via AP)On one hand, she noted infection rates across the country have been leveling off, but, she said, COVID-19 variants such as the highly transmissible so-called British strain, are poised to surge. This threatens to destroy what progress has been made.   Walensky also recognized that pandemic fatigue is winning out and people have begun ignoring measures that she says have successfully contributed to driving down U.S. infection rates.   The CDC director said this is occurring just as the United States begins a program to vaccinate the entire nation over the course of three or four months.  Walensky urged Americans to keep wearing masks and communities to encourage mask use. She advocated for precautions such as avoiding travel, crowds and to continue practicing personal hygiene, whether it is government-mandated or not.   Texas’ Republican Governor Greg Abbott Tuesday lifted his state’s mask-wearing mandate, along with all other restrictions on businesses, saying Texas has mastered the daily habits necessary to avoid getting COVID-19. 
…

The World Health Organization says one in 10 people worldwide is expected to suffer from hearing loss by 2050. But in the United States, health officials say around 20 percent of America’s adult population is already experiencing some level of hearing loss and the coronavirus pandemic has exposed the problem to a greater extent. As the country marks FILE – Director of Empowering Deaf Society Mangai Sutharsan, puts on a partially transparent mask following the coronavirus disease (COVID-19) outbreak in Ilford, London, Britain, July 29, 2020.Experts are also worried about the next generation of Americans. While children with hearing problems often show poor school performance, hearing loss in teenagers has been on the rise.  Currently, one in five teens exhibits some level of loss, according to the Hearing Loss Association of America. This number has increased by more than 30 percent since the 1990s, which to some extent has to do with “listening to loud music,” Shoup said. About 466 million people worldwide struggle with disabling hearing loss, according to the WHO. By 2050, this number could rise to 900 million people. In 2007, the World Health Organization designated March 3 as World Hearing Health Day to raise awareness of the growing numbers of those suffering from hearing loss and the importance of hearing health care. FILE – Resound LiNX2 connected smart hearing aids are shown at ShowStoppers during the 2017 Consumer Electronic Show (CES) in Las Vegas, Nevada, Jan. 5, 2017.In 2017, the National Institute on Deafness & Other Communication Disorders, whisih is part of the National Institutes of Health, said that 48 million Americans suffer some type of hearing loss.  “The growing health problem of hearing loss is often unrecognized in U.S. adults, adolescents and children and it leads to a long list of problems including depression, isolation, academic delays, impaired communication and cognitive decline. We are grateful that this awareness day was created to shine a light on the significance of hearing loss,” said Shoup. Shoup is also the executive director of the Callier Center for Communication Disorders and a professor of speech, language and hearing in the School of Behavioral and Brain Sciences at the University of Texas at Dallas.  FILE – An employee of GN, the world’s fourth largest maker of hearing aids, demonstrates the use of ReSound LiNX in Vienna, Nov. 22, 2013.“We also look to this day to help educate the public on the importance of seeing an audiologist for professional evaluation and management of hearing and balance difficulties,” she said.   According to the National Institute on Deafness and other Communication Disorders, approximately 20 percent of American adults aged 20 to 69 have some trouble with hearing and approximately 28.8 million could benefit from the use of hearing aids.    Some signs of hearing loss may include:…  Suddenly having to turn up the volume of the television, radio, or stereo and having other family members complain that the volume is too loud. Difficulty understanding people speaking to you and asking people to repeat themselves. Difficulty with phone conversations and understanding the other person. Sudden inability to hear the door bell, the dog barking, and other household sounds. People telling you that you speak too loudly. Ringing in the ears.   
…

Scientists are warning that a variant of the novel coronavirus that was first detected in Brazil could reinfect people already recovering from COVID-19.  The P.1 variant has spread to more than 20 countries since it was first detected last November in the Amazonian region city of Manaus.  A joint study by scientists in Britain and Brazil says the variant is 1.4 to 2.4 times more transmissible than the original version of the coronavirus.  Manaus was struck by an initial wave of COVID-19 infections in April and May of last year.  According to researchers, by October almost 80% of recovering coronavirus patients should have developed antibodies that would have made them immune to the virus. Peru will Receive a Second Vaccine Wednesday to Battle COVID-19Peru to receive the first batch of 50,000 doses of Pfizer vaccine Wednesday    But 25% to 61% of those who had recovered from a first bout of COVID-19 were reinfected with the P.1 variant, according to the study, which has not been peer-reviewed.Scientists are worried that new and more infectious variants of the coronavirus that causes COVID-19 could be resistant to vaccine now being distributed around the world.  But Nuno Faria, a virologist at Imperial College London who co-led the study, says it is too early to determine if the situation in Brazil with the P.1 variant will also occur elsewhere.  The release of the study on the P.1 variant coincided with official data from Brazil showing it had recorded its highest single-day number of COVID-19 deaths with 1,641.The COVID-19 pandemic has sickened more than 114.8 million people around the globe since it was first detected in central China in late 2019, including 2.5 million deaths, according to Johns Hopkins University’s Coronavirus Resource Center.The pandemic has also led to what the United Nations Children’s Fund (UNICEF) has described as an “education emergency,” with more than 168 million children around the world locked out of the classroom for nearly a year.   UNICEF says 98 million children across Latin America and the Caribbean account for the majority of students who have missed in-person learning.  U.S. country music superstar Dolly Parton tried to inject hope and encouragement Tuesday as she was injected with her first dose of the Moderna vaccine. In a short video she posted on Twitter, the 75-year-old singer-songwriter received the vaccine at Vanderbilt University Health Center in Nashville, Tennessee.Dolly gets a dose of her own medicine. @VUMChealthpic.twitter.com/38kJrDzLqC— Dolly Parton (@DollyParton) March 2, 2021Before getting the shot, Parton revamped one of her most famous songs, “Jolene,” to encourage viewers to get the COVID-19 vaccine.
…

To mark World Hearing Day, the World Health Organization is calling for action to stem the epidemic of hearing loss, which currently affects 1.5 billion people globally.  A roadmap for action is contained in WHO’s first World Report on Hearing.     WHO officials warn nearly 2.5 billion people will be living with some degree of hearing loss by 2050 if nothing is done to prevent or mitigate this condition.  Nearly a third, they say will require hearing rehabilitation.   The personal and economic cost of this condition is huge.  Many people who are deaf or suffer from varying degrees of hearing loss are stigmatized and spend much of their lives in isolation.   Additionally, WHO reports unaddressed hearing loss costs the global economy nearly $1 trillion  each year.   WHO technical officer on ear and hearing care Shelly Chadha says much of this hearing loss can be prevented.   “Many of the causes, for example, hearing loss which is caused by listening to loud music over one’s headphones and earphones — this can be prevented.  As can be hearing loss, which is caused by loud noise in one’s workplace.  Other common causes of hearing loss — ear infections, rubella, meningitis — these are causes which can be prevented by established public health strategies.”     Chadha notes almost 60% of hearing loss in children is due to avoidable causes such as ear infections and birth complications.  She says solutions are available.  She says hearing technologies, such as hearing aids and cochlear implants accompanied by rehabilitative therapy can mitigate the adverse effects of hearing loss.   “Millions of people across the world are already benefiting from these interventions.  But they are a bit of an exclusive group because what we estimate is that across the world only about 17 percent of people who need these services actually are able to benefit from them,” she said.     People in low-income countries are the most underserved because they lack the specialists, audiologists and speech therapists who can provide the care required.  WHO says this gap can be closed by integrating ear and hearing care into national primary health care services.   WHO calls this a great investment, noting for every dollar invested in hearing loss care, governments can expect a return of nearly $16.  
…

Merck will help its pharmaceutical competitor Johnson & Johnson make the single-shot coronavirus vaccine. That was announced on Tuesday by President Joe Biden.VOA’s White House bureau chief Steve Herman was in the room when the president also said he wants every American educator to receive at least one vaccine dose by the end of this month, as part of the effort to get the country back to normal as quickly as possible.President Biden, speaking in the White House State Dining Room, says the cooperation among competitors to produce more doses and other actions will speed up the timeline by two months to have enough vaccine to inoculate every adult American.“Here’s what all this means – we’re now on track to have enough vaccine supply for every adult in America by the end of May.”The president, in response to a reporter’s question, said he hopes that “by this time next year” or sooner, things will be back to normal.  
…

It’s the sort of chance that comes along just once in a blue Moon: a Japanese billionaire is throwing open a private lunar expedition to eight people from around the world. Yusaku Maezawa, an online fashion tycoon, was announced in 2018 as the first man to book a spot aboard the lunar spaceship being developed by SpaceX. Maezawa, who paid an undisclosed sum for the trip expected to launch around 2023, originally said he planned to invite six to eight artists to join him on the voyage.But on Wednesday, in a video posted on his Twitter account, he revealed a broader application process. “I’m inviting you to join me on this mission. Eight of you from all around the world,” he said. “I have bought all the seats, so it will be a private ride,” he added. Maezawa said his initial plan of inviting artists had “evolved” because he came to believe that “every single person who is doing something creative could be called an artist.” The Japanese entrepreneur said applicants would need to fulfill just two criteria: being ready to “push the envelope” creatively, and being willing to help other crew members do the same. In all, he said around 10 to 12 people will be on board the trip, which is expected to loop around the Moon before returning to Earth. The application timeline for spots on the trip calls for would-be space travelers to pre-register by March 14th, with initial screening carried out by March 21st. No deadlines are given for the next stages – an “assignment” and an online interview – but final interviews and medical checkups are currently scheduled for late May 2021, according to Maezawa’s website. Maezawa and his band of merry astronauts will become the first lunar voyages since the last US Apollo mission in 1972 – if SpaceX can pull the trip off.   Last month, a prototype of its Starship crashed in a fireball as it tried to land upright after a test flight, the second such accident, after the last prototype of the Starship met a similar fate in December. The company hopes the reusable, 394-foot (120-meter) rocket system will one day carry crew and cargo to the Moon, Mars and beyond. 
…

Texas is lifting its mask mandate, Gov. Greg Abbott said Tuesday, making it the largest state to no longer require one of the most effective ways to slow the spread of the coronavirus.The announcement in Texas, where the virus has killed more than 42,000 people, rattled doctors and big city leaders who said they are now bracing for another deadly resurgence. One hospital executive in Houston said he told his staff they would need more personnel and ventilators.Texas Governor Greg Abbott delivers an announcement in Montelongo’s Mexican Restaurant on March 2, 2021, in Lubbock. Abbott announced that he is rescinding executive orders that limit capacities for businesses and the state wide mask mandate.Federal health officials this week urgently warned states to not let their guard down, warning that the pandemic is far from over.Abbott, a Republican, has faced sustained criticism from his party in America’s biggest red state over the statewide mask mandate — which was imposed eight months ago — as well as business occupancy limits that Texas will also scuttle next week. The mask order was only ever lightly enforced, even during the worst outbreaks of the pandemic.”Removing statewide mandates does not end personal responsibility,” said Abbott, speaking from the crowded dining room of a restaurant in Lubbock, surrounded by several people not wearing masks.”It’s just that now state mandates are no longer needed,” he said.The repeals will take effect March 10.The full impact of Texas’ reversal was still coming into focus. Mark Cuban, owner of the NBA’s Dallas Mavericks, said he had no immediate plans to change the limits on fans at home games. Their biggest crowd so far this season was about 3,000 spectators.Restaurant owners began confronting whether they, too, would relax COVID-19 safeguards in their dining rooms. And school administrators scrambled to figure out how the end of the mask mandate would impact the state’s 5 million public school students.”While we’ve made significant progress, I’d hate to have that go away,” said Tinku Saini, the CEO of Tarka Indian Kitchen, which has locations across Texas. He said Abbott’s announcement left him with mixed feelings, and that he would now allow customers to go maskless but still require face coverings for staff and keep tables spread apart.Abbott joins a growing number of governors across the U.S. who are easing coronavirus restrictions. Like the rest of the country, Texas has seen the number of cases and deaths plunge. Hospitalizations are at the lowest levels since October, and the seven-day rolling average of positive tests has dropped to about 7,600 cases, down from more than 10,000 in mid-February.Only California and New York have reported more COVID-19 deaths than Texas.”Absolutely reckless,” California Gov. Gavin Newsom, a Democrat, tweeted in response to Abbott’s announcement.Texas is doing away with the restrictions just ahead of the spring break holiday, which health experts worry could lead to more spread as people travel.”The fact that things are headed in the right direction doesn’t mean we have succeeded in eradicating the risk,” said Dr. Lauren Ancel Meyers, a professor of integrative biology and director of the University of Texas COVID-19 Modeling Consortium.She said the recent deadly winter freeze in Texas that left millions of people without power — forcing families to shelter closely with others who still had heat — could amplify transmission of the virus in the weeks ahead, although it remains too early to tell. Masks, she said, are one of the most effective strategies to curb the spread.The top county leader in Houston, Harris County Judge Lina Hidalgo, called the announcement “wishful thinking” and said spikes in hospitalizations have followed past rollbacks of COVID-19 rules.”At worst, it is a cynical attempt to distract Texans from the failures of state oversight of our power grid,” said Hidalgo, a Democrat.Dr. Joseph Varon, chief medical officer at Houston’s United Memorial Medical Center, said he called the hospital’s top leaders immediately after Abbott’s announcement and said they will need more staff and ventilators.”I am just concerned that I am going to have a tsunami of new cases,” Varon said. “I truly hope I am wrong. But, unfortunately, history seems to repeat itself.”Early in the pandemic, Abbott stripped local officials of their power to implement tougher COVID-19 restrictions, but now says counties can impose “mitigation strategies” if virus hospitalizations exceed 15% of all hospital capacity in their region. However, Abbott forbade local officials from imposing penalties for not wearing a face covering.Retailers and other businesses will also still be allowed to impose capacity limits and other restrictions on their own.Abbott imposed the statewide mask mandate in July during a deadly summer surge. But enforcement was spotty at best, and some sheriffs refused to police the restrictions at all. And as the pandemic dragged on, Abbott ruled out a return to tough COVID-19 rules, arguing that lockdowns do not work.Politically, the restrictions elevated tensions between Abbott and his own party, with the head of the Texas GOP at one point leading a protest outside the governor’s mansion. Meanwhile, mayors in Texas’ biggest cities argued that Abbott wasn’t doing enough.Most of the country has lived under mask mandates during the pandemic, with at least 37 states requiring face coverings to some degree. But those orders are increasingly falling by the wayside: North Dakota, Montana and Iowa have also lifted mask orders in recent weeks.In Texas, it was only last week that emergency restrictions on restaurants and businesses were relaxed in the Rio Grande Valley, which has been walloped by the virus like few other places in America.”I appreciate Governor Abbott’s desire to return to normalcy, but I remained concerned that, at least in Hidalgo County, we may be moving too quickly,” Hidalgo County Judge Richard Cortez said. 
…

The global COVAX vaccine distribution plan aims to deliver tens of millions of vaccine doses to low-income countries — many of them in Africa – in the coming months, top global health officials say, describing this as a turning point in the quest to quash the coronavirus pandemic.The world’s largest, fastest, and most ambitious vaccine drive delivered 11 million vaccine doses Tuesday to Angola, Cambodia, the Democratic Republic of the Congo and Nigeria. Between now and the end of May, said WHO chief Tedros Adhanom Ghebreyesus, the COVAX facility will deliver 270 million doses to 142 participating countries and economies.The global initiative was set up last April to ensure that poorer nations aren’t left out of the worldwide scramble for vaccine access. The program, which is projected to cost about $11 billion, is funded by donor nations, foundations and corporations. It is part of the Access to COVID-19 Tools Accelerator, a global collaboration that works on the development, production, and equitable access to tests, treatments, and vaccines.Last week, the West African nation of Ghana became the first to benefit from COVAX, receiving 600,000 doses of the AstraZeneca vaccine. Among the first recipients were President Nana Akufo-Addo and the first lady, who received their shots on national television Monday in what he said was an effort to boost public confidence in the vaccine. Akufo-Addo plans to vaccinate the rest of his country by the end of the year, he said.  “The world has seen already the great value of the COVAX facility,” he told journalists via teleconference on Tuesday. “COVID-19 is a global problem. It requires a global solution. Unless every country is protected, no country will be safe. We all fell together. Let us all rise together.”Ivory Coast also launched its COVAX vaccination program this week.“We’ve now see Africa’s first vaccinations and the COVAX doses in Ghana and Ivory Coast. Truly moving ceremonies in both countries were held yesterday,” said UNICEF director Henrietta Fore. “But what took place on Monday is more than a feel-good story that speaks to our collective best natures. It is a necessary first step that speaks to our collective best interests. The only way out of this pandemic is to ensure vaccination is available around the globe and that people from less wealthy countries are not left behind in the race to be protected.”Tedros says while the vaccine deliveries are good news, he’s thinking much bigger.  “When the history of the pandemic is written, I believe that the accelerator and COVAX will be one of the standout successes,” he said. “This is an unprecedented partnership that will not only change the course of the pandemic, but will also change the way the world responds to future health emergencies.”Officials say the next step is to bring vaccine manufacturing to the continent. Currently, most vaccines available to the continent come from the world’s largest vaccine manufacturer, the Serum Institute of India. Akufo-Addo said Ghana is working on a plan to manufacture vaccines locally. And Dr. John Nkengasong, head of the Africa Centers for Disease Control and Prevention, said the African Union will meet next month to discuss how to do this as a continent.“All of that speaks to the need for our own ability to stand up and say that we, as the people, of 1.2 billion people, will continue to invest in our own health security, our economic security that increasingly is being threatened by covid-19,” he said. “It is this perspective that we look forward to working with all countries that will be receiving these COVAX vaccines to ensure that they are distributed effectively, [to] provide the appropriate support from the African CDC and partnerships that will enable us to distribute these vaccines in a timely fashion.”This vaccine rollout, Nkengasong said, is the first step in a thousand-mile journey. But in this voyage, he said, the African continent is — finally — keeping step with the rest of the world.   
…

U.S. pharmaceutical giant Merck has agreed to help manufacture rival Johnson & Johnson’s new coronavirus vaccine to help speed production of millions of new doses of the single shots to inoculate more Americans in the coming months, White House officials said Tuesday.Johnson & Johnson has encountered unexpected production problems, even as it won emergency use approval last weekend for the vaccine. The company has manufactured 3.9 million doses so far, but says it is on pace to produce 100 million doses by the end of June.President Joe Biden is set to spell out details of the agreement between the two pharmaceutical companies later Tuesday. But officials familiar with the deal say Merck will use two sites in the U.S., one to help make the vaccine and the other to provide “fill-finish” services, the final stage in the production process in which the vaccine is placed in vials and packaged for distribution.The Merck agreement with its drug-making rival could sharply increase the number of doses Johnson & Johnson could make on its own, the officials said.  Merck failed in its efforts to develop its own coronavirus vaccine, but the company has made vaccines for a century. It is the sole U.S. supplier of the combination childhood vaccine that protects against measles, mumps and rubella. It developed Gardasil, which protects against the human papillomavirus, while the Food and Drug Administration approved its Ebola vaccine in 2019.With the approval of the single-shot Johnson & Johnson vaccine, the U.S. now has three medical treatments to fight the spread of the virus, along with two-shot regimens produced by drug makers Pfizer-BioNTech and Moderna.Pharmacy technicians fill syringes with a COVID-19 vaccine at an inoculation site in Portland, Maine, March 2, 2021.After the FDA’s approval of the Johnson & Johnson vaccine, the company said it would immediately ship nearly 4 million doses in the United States, and a total of 20 million by the end of March. That is 17 million less than originally expected although the company still says it expects to markedly increase its production pace in coming months.A top Johnson & Johnson executive told Congress last week that it hopes to manufacture 1 billion doses worldwide by the end of 2021.The mass inoculations in the U.S. are first targeting health care workers, older people living in nursing homes, such essential personnel as police and firefighters, teachers, people 65 and older and those with underlying health problems.U.S. health officials are hoping that the country’s sense of normalcy might return by the end of 2021, but that is dependent on the widespread vaccination of millions of adults and later, possibly children.  So far, 75 million vaccine doses have been administered to about 15% of the country’s adult population, with half that percentage receiving both shots of the two-shot Pfizer and Moderna regimens. About 1.7 million shots are being administered daily.The spread of the coronavirus has slowed in the U.S. But 50,000 or 60,000 new cases are still being diagnosed each day and another 1,500 people or so are dying.The U.S. has totaled more than 514,000 deaths and more than 28.6 million infections, both higher totals than in any other country, according to Johns Hopkins University. 
…

President Emmerson Mnangagwa has relaxed Zimbabwe’s coronavirus lockdown, saying new infections continue to decrease. Vendors welcome the move but say they need help buying protective equipment so they can safely operate. Meanwhile, the main opposition party says more needs to be done to help the country bounce back from the pandemic.In a nationally televised address late Monday, President Emmerson Mnangagwa said Zimbabwe was with immediate effect relaxing most lockdown regulations – which the country reimposed early January following a spike in cases.“It is noteworthy that the number of COVID-19 positive cases, fatalities and hospitalizations continue to steadily decrease. We must, however, remain alert and on guard to maintain this positive momentum attained so far. The government has rolled out the first phase of the national COVID-19 vaccination program which targets the front-line workers, security sector, and members of the media, the elderly and those with underlying conditions. More vaccines are coming and people will have the opportunity to be vaccinated,” said the president.The country started a vaccination drive last month after receiving 200,000 doses of the Sinopharm coronavirus vaccine donated by Chinese government.Samuel Wadzai welcomes, March 2, 2021, the government’s decision to allow informal traders to resume operating.(Columbus Mavhunga/VOA)Samuel Wadzai leads the activist group Vendors Initiative Social and Economic Transformation in Zimbabwe. He welcomed the government’s decision to allow informal traders to resume operating.“This is going to significantly help us to survive. The lockdown itself was causing a lot of suffering. The informal sector was heavily affected,” he said.But Wadzi wants the government to help vendors obtain personal protective equipment to avoid a new surge in cases.“The majority of informal traders are unable to buy those PPEs given that they have been out of business a long time. We really need to go back to work and cover for the lost revenue during the lockdown,” he said.Fadzayi Mahere is the spokeswoman for the country’s main opposition party, the Movement for Democratic Change Alliance, and has just recovered from COVID-19, the illness caused by the coronavirus. She said the government has been using lockdowns to restrict freedoms.Fadzayi Mahere says March 2, 2021, Zimbabwe needs a plan to bounce back from the coronavirus pandemic. (Columbus Mavhunga/VOA)She also said Zimbabwe needs a plan to bounce back from the pandemic.“There is no post-COVID economic revival plan. There is no post-COVID social support plan. Both big and small businesses are facing closure and there is no policy plan to ease the pressure. The question of social safety nets remains wholly unanswered. We have ordinary people in rural areas, townships and vendors, more vulnerable than ever. Nothing has been done to address their plight,” said Mahere.The government has offered small monthly grants to ease people’s suffering, but the money is not enough to buy a dozen loaves of bread.Zimbabwe currently has about 36,000 confirmed infections and close to 1,470 deaths, according to the Johns Hopkins University, which is tracking the global outbreak. 
…

France will now vaccinate people aged 65 years and older with the COVID-19 vaccine jointly developed by Oxford University and British-Swedish drugmaker AstraZeneca.   The decision was announced Tuesday by Health Minister Olivier Veran during a televised interview.  Veran said anyone older than the age of 50 with pre-existing conditions can receive the Oxford-AstraZeneca vaccine, “including those between 65 and 74.” France was among many European nations that refused to approve the Oxford-AstraZeneca for its elderly citizens.  The developers did not enroll many people in those age groups for their large-scale clinical trials, leading to a lack of data about its potential efficacy.  French President Emmanuel Macron even went so far as describing the vaccine as “quasi-ineffective.”   FILE – A medical worker holds a vial of the Oxford-AstraZeneca vaccine against the coronavirus disease (COVID-19) in a mass vaccination center at the Cecchignola military compound, in Rome, Italy, Feb. 23, 2021.But health officials say further data from clinical trials has proved its efficacy among older people.  The reversal is sure to jumpstart France’s slow vaccination campaign, which has been hampered by a shortage of vaccines from Pfizer-BioNTech and Moderna.  France’s change of heart coincides with a real-world study conducted in Britain that found the COVID-19 vaccines developed by Pfizer-BioNTech and Oxford University-AstraZeneca are highly effective in protecting elderly people from the disease after receiving just one shot. Researchers at Public Health England say the respective two-dose vaccines are more than 80% effective at preventing people in their 80s from being hospitalized around three to four weeks after the first shot is administered.  FILE – A woman receives the Pfizer BioNTech vaccine at the Pasteur Institute during a vaccination program, in Paris, Jan. 21, 2021.The study also found that the first dose of the Pfizer-BioNTech vaccine was between 57% and 61% effective in preventing COVID-19 infections among people at least 70 years old, while the Oxford-AstraZeneca vaccine was between 60% and 73% effective. The study, posted online Monday, has not undergone the customary peer-review process.  Britain was the first European country to approve the Oxford-AstraZeneca vaccine for all of its citizens regardless of age.   US sticks to two-dose regimenIn the United States, Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, told The Washington Post  Tuesday the United States will stick with the two-dose regimen of both the Pfizer-BioNTech and the Moderna vaccines. A growing number of public health experts have urged government health officials to use millions of doses intended to be used as second shots instead be used as first doses, as millions of adult Americans have not been inoculated due to an acute shortage of vaccines. But Dr. Fauci warned that switching to a single-dose strategy could leave people less protected and enable the growing number of variants to spread.  FILE – Workers for the U.S. federal government prepare the coronavirus disease (COVID-19) vaccines at a new mass vaccination center in Oakland, California, Feb. 16, 2021.The nation’s leading infectious-disease expert tells the Post that “the gap between supply and demand is going to be diminished and then overcome” very soon as both Pfizer and Moderna fulfill their commitment to provide 220 million total doses by the end of March, along with Johnson & Johnson’s pledge to deliver 20 million doses of its one-shot COVID-19 vaccine this month.   New cases on the riseThe World Health Organization said new coronavirus cases increased globally for the first time in seven weeks, and officials expressed concern that cases could again rise significantly.      “We need to have a stern warning for all of us that this virus will rebound if we let it,” Maria Van Kerkhove, WHO technical lead for COVID-19, said Monday at a news briefing at the agency’s headquarters in Geneva.     WHO Director-General Tedros Adhanom Ghebreyesus said the rise in cases occurred in four regions: the Americas, the eastern Mediterranean, Europe and Southeast Asia. He said the development was “disappointing but not surprising” and said part of the spike appeared to be the result of the “relaxing of public health measures.”     FILE – Health staff attends to a patient at the coronavirus disease (COVID-19) dedicated ICU unit of the Tras-Os-Montes E Alto Douro Hospital, amid the COVID-19 pandemic in Vila Real, Portugal, Feb. 22, 2021.Michael Ryan, director of WHO’s emergencies program, said, “Right now, the virus is very much in control” and said it was “unrealistic” to think the pandemic might be stopped by the end of the year.     The warnings come after a sharp fall of coronavirus cases and deaths in many parts of the world, which along with vaccine developments, had led to hopes that the spread of the coronavirus would continue on a downward trend.     In the United States, health officials are warning that another surge in cases could be on the horizon, as newer and more infectious variants of the coronavirus that causes COVID-19 are growing more frequently.      The new upward trend in cases comes as most states are easing coronavirus restrictions.  
…

One in four of the world’s population will suffer from hearing problems by 2050, the World Health Organization warned Tuesday, calling for extra investment in prevention and treatment. The first-ever global report on hearing said that the causes of many of the problems — such as infections, diseases, birth defects, noise exposure and lifestyle choices — could be prevented.  The report proposed a package of measures, which it calculated would cost $1.33 per person per year. Against that, it set the figure of nearly $1 trillion lost every year because the issue was not being properly addressed. “Failure to act will be costly in terms of the health and well-being of those affected, and the financial losses arising from their exclusion from communication, education and employment,” said the report. One in five people worldwide have hearing problems currently, it said. But the report warned: “The number of people with hearing loss may increase more than 1.5-fold during the next three decades” to 2.5 billion people — up from 1.6 billion in 2019. Of the 2.5 billion, 700 million would in 2050 have a serious enough condition to require some kind of treatment, it added — up from 430 million in 2019. Much of the expected rise is the result of demographic and population trends, it added. Poor access to treatment A major contributor to hearing problems is a lack of access to care, which is particularly striking in low-income countries where there are far fewer professionals available to treat them. Since nearly 80% of people with hearing loss live in such countries, most are not getting the help they need. Even in richer countries with better facilities, access to care is often uneven, the report said. And a lack of accurate information and the stigma surrounding ear disease and hearing loss also prevents people getting the care they need. “Even among health-care providers, knowledge relevant to prevention, early identification and management of hearing loss and ear diseases is commonly lacking,” it noted. The report proposed a package of measures, including public health initiatives from reducing noise in public spaces to increasing vaccinations for diseases such as meningitis that can cause hearing loss. It also recommended systematic screening to identify the problem at key points in people’s lives. Among children, it said, hearing loss could be prevented in 60% of cases. “An estimated 1 trillion U.S. dollars is lost each year due to our collective failure to adequately address hearing loss,” WHO director-general Tedros Adhanom Ghebreyesus said in the report. “While the financial burden is enormous, what cannot be quantified is the distress caused by the loss of communication, education and social interaction that accompanies unaddressed hearing loss.” 
…

A third COVID-19 vaccine is heading to clinics and pharmacies across the United States. But U.S. health officials are warning that another surge in cases could be on the horizon.Regulators authorized the vaccine from pharmaceutical company Johnson & Johnson over the weekend. Nearly 4 million doses are expected to be available at vaccination sites beginning as soon as Tuesday.But after a sharp fall over the past several weeks, the number of COVID-19 cases and deaths has increased again. Experts are concerned that newer, more infectious variants of the coronavirus that causes COVID-19 may be taking over.The reversal comes as most states are easing restrictions that contain the disease.”Now is not the time to relax the critical safeguards that we know can stop the spread of COVID-19,” Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention, said at a press briefing of the White House COVID-19 Response Team.Though the numbers have declined, the National Guard personnel check in people as they wait to receive a COVID-19 vaccination, Feb. 26, 2021, in Shelbyville, Tennessee.”Please hear me clearly,” Walensky said. “At this level of cases with variants spreading, we stand to completely lose the hard-earned ground we have gained. These variants are a very real threat to our people and our progress.”Effective against severe diseaseThe Johnson & Johnson vaccine was about 85% effective in preventing severe illness in a clinical trial spanning eight countries on three continents.That includes South Africa, where a more transmissible coronavirus variant dominates cases.”Even though the vaccine itself was not specifically directed against [that variant], it did extremely well when it came to preventing severe critical disease,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to President Joe Biden, noted at the briefing.Though three vaccines are now available, experts are urging people not to try to pick and choose.”All three vaccines are safe and highly effective at preventing what we care about most, and that’s very serious illness and death,” Marcella Nunez-Smith, the Biden administration’s COVID-19 health equity task force chair, told reporters at the briefing.”As a physician, I strongly urge everyone in America to get the first vaccine that is available to you when it is your turn,” she said. “If people want to opt for one vaccine over another, they may have to wait. Time is of the essence. Getting vaccinated saves lives.”Easier to useUnlike the shots from Pfizer-BioNTech and Moderna, the Johnson & Johnson vaccine requires only one shot and does not need to be frozen.A pharmacist prepares a syringe with the Pfizer-BioNTech COVID-19 vaccine at a COVID-19 vaccination site at NYC Health + Hospitals Metropolitan, in New York, Feb. 18, 2021.This easier-to-use vaccine could be distributed in pop-up vaccination sites, mobile clinics or other places without freezers.Immediately after regulators gave the go-ahead, Johnson & Johnson began shipping its entire 3.9 million dose inventory of the vaccine. The company expects to deliver another 16 million doses by the end of March.But COVID-19 response coordinator Jeff Zients said supplies will be “uneven” for the next couple of weeks. He said most of the doses will arrive in late March.He urged people to continue wearing masks and social distancing, and to get vaccinated when their turn comes.”There is a path out of this pandemic,” he said, “but how quickly we exit this crisis depends on all of us.” 
…

More than 86,000 people died from drug overdoses last year in the U.S. – a massive increase of just over 24 percent. It is an epidemic that as VOA’s Veronica Balderas Iglesias reports, has been shoved in the shadows by the pandemic – but is no less serious a public health issue.Camera: Veronica Balderas Iglesias  Produced by: Veronica Balderas Iglesias  
…

Scientists with the British Antarctica Survey (BAS) say a huge iceberg — larger than New York City — has broken off from the northwestern Brunt Ice Shelf in Antarctica, almost 10 years after scientists discovered the first cracks. In a statement on its website, the BAS says the iceberg broke away Friday and that it covers about 1,270 square kilometers. The BAS says the mass is about 150 meters thick.  The agency said Halley Research Station, also situated on Brunt Ice Shelf, is not expected to be impacted as it is located on an area of the ice shelf still connected to the continent. The BAS took the precaution of moving the station in 2016 to avoid the paths of cracks in the ice its staff had been observing. In the statement, the BAS director, Professor Dame Jane Francis, said agency scientists were expecting the break, known as calving, to happen, after daily monitoring of the area with GPS instruments and satellite imagery. Francis said the iceberg is expected to either move away or run aground not far from the Brunt Ice Self. 
…

An international study shows an upward trend in support for receiving COVID-19 vaccines in several countries compared to the end of 2020, with the biggest increase in Britain and Sweden.  Multinational communication firm Kekst CNC Monday published the results of the survey conducted in six countries – Britain, France, Germany, Japan, Sweden, and United States. The poll indicated 89% of Britons were in favor of getting vaccinated now, compared to 65% last September.The AstraZeneca vaccine is prepared in the COVID-19 vaccination center at the Odeon Luxe Cinema in Maidstone, Britain, Feb. 10, 2021.In Sweden, 76% of those interviewed were in favor of inoculation, compared to 51% in September 2020.  The study shows that 68% of men worldwide support vaccination, the ratio is lower among women at 55%. Older and middle-aged people have become more likely to get a vaccine since September, the survey found.   The study also shows that 75% of Britons are pleased with the pace of the vaccination campaign in the country, but the ratio drops in the other countries surveyed, to 32% in U.S., 22% in France and 20% in Sweden. Kekst CNC conducted the survey in mid-February over ten days, with samples of 1,000 adults in each country and margin of error of 3.3 percent for all participating counties.   Sunday, a U.S. Centers for Disease Control and Prevention advisory panel endorsed the Johnson & Johnson vaccine, voting overwhelmingly to recommend the shot for adults older than 18.  CDC recommendations are not binding but are widely respected by medical institutions and professionals. CDC Director Rochelle Walensky later approved the panel’s recommendations.FILE – Vials of Johnson & Johnson’s Janssen coronavirus disease (COVID-19) vaccine candidate are seen in an undated photograph.Sunday’s CDC endorsement came one day after the U.S. Food and Drug Administration formally authorized the use of the one-dose vaccine. Nearly 4 million doses of the Johnson & Johnson vaccine will be distributed and available as early as Tuesday morning, according to a senior administration official. This vaccine, the third to be approved for use in the United States, will be distributed to states, tribes and territories proportional to their populations – the same way the Pfizer-BioNTech and Moderna vaccines have been distributed. Health officials in the U.S. welcomed the third vaccine, which has been eagerly awaited largely because it requires only one shot, but officials urged Americans to receive whichever vaccine is first available to them, reiterating that all three have proved to be safe and effective. The Johnson & Johnson vaccine is 85% effective against serious illness, hospitalization and death from COVID-19, the disease caused by the coronavirus, according to data from a study that spanned three continents. The shot kept its protection even in the countries where the South African variant is spreading. Johnson & Johnson is also seeking authorization for emergency use of its vaccine in Europe and from the World Health Organization. As of Sunday evening, about 28.6 million Americans have had COVID-19 and more than 513,000 have died from the disease, according to the Johns Hopkins Coronavirus Research Center. The U.S. continues to lead the world in the number of coronavirus infections, followed by India with more than 11 million infections and Brazil with more than 10.5 million.
…

The Philippines launched its national coronavirus vaccination campaign Monday amid widespread public skepticism and a struggle to procure vaccines.   Dr. Gerardo Legaspi, the director of the state-run Philippine General Hospital in Manila, received the first dose of the CoronaVac vaccine developed by China-based Sinovac Biotech Limited.  The doctor’s inoculation came just hours after President Rodrigo Duterte greeted the arrival of 600,000 doses of Sinovac donated by Beijing. The Philippines is the last Southeast Asian nation to receive a COVID-19 vaccine supply.  The Duterte administration is aiming to vaccinate 70 million of its citizens, but some public opinion polls have revealed a resistance among a majority of people due to uncertainty over the safety and efficacy of the CoronaVac vaccine.Used vials of China’s Sinovac vaccine are shown during the first batch of vaccination at the Lung Center of the Philippines in Quezon city, Philippines on March 1, 2021.But Carlito Galvez, who is leading the Philippines’ vaccine procurement efforts, urged his compatriots to get the first vaccine that becomes available.  “Let’s not wait for the best vaccine. There’s no such thing,” Galvez said in a speech at the Philippine General Hospital.  “The best vaccine is the one that’s safe and effective, and arrives early.” But just receiving vaccines has been an issue.  An expected shipment of  525,600 doses of the AstraZeneca-Oxford University vaccine that was due Monday has been postponed due to supply problems.  The COVID-19 pandemic has devastated the Pacific archipelago, sickening more than 576,000 people, including 12,318 deaths, the second-highest in the region.  President Duterte has vowed to ease some of the restrictions imposed in an effort to boost the Philippine economy once more vaccines are available.   
…